ARVO/Champalimaud Award Lecture
Today, May 5th 2015, saw the annual ARVO/Champaimaud Lecture in Denver, as a part of the annual ARVO meeting. The event marked another opportunity to recognise the work developed by the seven scientists whose work was honoured with the 2014 António Champalimaud Vision Award.
With the participation of Leonor Beleza, President of the Champalimaud Foundation, Alfred Sommer, President of the Champalimaud Award jury, Joshua Sanes, member of the Award jury, and two of the 2014 Champalimaud Award Laureates, this event celebrated the work leading to the discovery of an effective treatment for two of the principal causes of vision loss worldwide.
In front of an audience of around 2000 vision specialists, Leonor Beleza stated that “It is my deep honour and indeed a personal feeling of fulfilment to be able to celebrate here today the culmination of a truly collaborative effort. The 2014 António Champalimaud Vision Award recognised the endeavours of an outstanding group of scientists who, working separately or together, converged to find an effective therapy for the treatment of ocular disease, in particular of macular degeneration and diabetic retinopathy. What is striking and gives me that feeling of fulfillment about the efforts of these men and women is that their work demonstrates the full power of translational science in its truest sense. So it is clear that the wider medical implications of this ground-breaking work are profound. And in recognising Drs Ferrara, Miller, Gragoudas, D’Amore, Adamis, King and Aiello, our award jury honoured not only the result of their collaboration, but the entire scientific process that led to it. This process has resulted in a breakthrough in our understanding of VEGF and the development of therapeutic solutions which have been saving the vision of an overwhelming number of people. The 2014 award is recognising indeed the work of some of the very finest scientists in the world.”
The annual ARVO meeting is one of the most important vision meetings worldwide, counting on the participation of the field’s leading figures. Along with the Champalimaud Lecture, many symposia, workshops and discussion groups are available for participants to engage on diverse vision-related themes.
The ARVO - The Association for Research in Vision and Ophthalmology – is the largest and most respected organisations for ophthalmology and vision research. With around 12000 members from more than 75 countries, the ARVO strives to promote investigation which contributes to advancing our understanding of the visual system and to preventing, treating and curing vision disorders.
To know more, please go to: